Successful treatment of IgM-mediated autoimmune hemolytic anemia with bortezomib.

@article{Carson2010SuccessfulTO,
  title={Successful treatment of IgM-mediated autoimmune hemolytic anemia with bortezomib.},
  author={Kenneth R. Carson and Lee G Beckwith and Jayesh Mehta},
  journal={Blood},
  year={2010},
  volume={115 4},
  pages={915}
}
Chronic cold agglutinin disease (CAD) is an acquired autoimmune hemolytic anemia (AIHA); usually due to the production of a monoclonal immunoglobulin M (IgM) protein directed against polysaccharide antigens on red blood cells.1,2 An occult lymphoproliferative disorder is often responsible for the production of the IgM paraprotein in patients with symptomatic CAD.3 The discovery of an underlying neoplastic process does guide therapeutic decisions in patients with severe symptomatic CAD… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

References

Publications referenced by this paper.
Showing 1-5 of 5 references

Velcade package insert (http://www.velcade.com/full_prescrib_velcade.pdf)

  • Kenneth R. Carson, Lee G. Beckwith, Jayesh Mehta
  • Accessed September
  • 2008

Similar Papers

Loading similar papers…